John Lauerman And Angelica Lavito Bloomberg
- All
- News
-
J&J Pause Over Blood-Clots To Educate Doctors, Study Cases: US Regulator
U.S. health officials urged a pause on the use of Johnson & Johnson's Covid-19 vaccine due to dangerous blood-clotting to give them time to educate doctors on how to treat the exceedingly rare disorder.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
-
J&J Pause Over Blood-Clots To Educate Doctors, Study Cases: US Regulator
U.S. health officials urged a pause on the use of Johnson & Johnson's Covid-19 vaccine due to dangerous blood-clotting to give them time to educate doctors on how to treat the exceedingly rare disorder.
-
Oxford Vaccine's 90% Efficacy In Covid Came In Younger Group
The dose of AstraZeneca Plc's Covid vaccine that showed the highest level of effectiveness was tested in a younger population than a bigger dose that showed less efficacy, according to the head of the U.S. Operation Warp Speed program.
